(Q38954023)

7 September 2017

title

Effects of antifungal agents in sap activity of Candida albicans isolates (English)

1 reference

7 September 2017

1 reference

Carolina Rodrigues Costa

1

1 reference

7 September 2017

Rosália Santos Amorim Jesuíno

2

1 reference

7 September 2017

Janine de Aquino Lemos

3

1 reference

7 September 2017

Orionalda de Fátima Lisboa Fernandes

4

1 reference

7 September 2017

Lúcia Kioko Hasimoto e Souza

5

1 reference

7 September 2017

Xisto Sena Passos

6

1 reference

7 September 2017

Maria do Rosário Rodrigues Silva

7

1 reference

7 September 2017

publication date

15 August 2009

1 reference

7 September 2017

number of pages

8

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

7 September 2017

volume

169

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

91-98

1 reference

Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography

7 September 2017

cites work

1 reference

12 December 2020

Metabolic specialization associated with phenotypic switching in Candidaalbicans

1 reference

12 December 2020

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

1 reference

12 December 2020

Antifungal prophylaxis with azole derivatives

1 reference

12 December 2020

Candida: a causative agent of an emerging infection

1 reference

12 December 2020

Emerging fungal diseases

1 reference

12 December 2020

Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole

1 reference

12 December 2020

Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals.

1 reference

12 December 2020

Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target

1 reference

12 December 2020

Antifungal agents--clinical pharmacokinetics and drug interactions

1 reference

12 December 2020

[Extracellular hydrolytic enzymes and their relevance during Candida albicans infections]

1 reference

12 December 2020

Molecular typing of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul.

1 reference

12 December 2020

Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001

1 reference

12 December 2020

Aspartyl proteinases of Candida albicans and their role in pathogenicity

1 reference

12 December 2020

Segregation of proteinase-negative mutants from heterozygous Candida albicans

1 reference

12 December 2020

Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity

1 reference

12 December 2020

Candida albicans proteinases and host/pathogen interactions

1 reference

12 December 2020

Distribution of secreted aspartyl proteinases using a polymerase chain reaction assay with SAP specific primers in Candida albicans isolates

1 reference

12 December 2020

In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis

1 reference

12 December 2020

Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis

1 reference

12 December 2020

Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans

1 reference

12 December 2020

Hydrolytic enzymes as virulence factors of Candida albicans

1 reference

12 December 2020

Candida albicans secreted aspartyl proteinases in virulence and pathogenesis

1 reference

12 December 2020

The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus

1 reference

12 December 2020

Drug pumping mechanisms in Candida albicans.

1 reference

12 December 2020

Characterization of switch phenotypes in Candida albicans biofilms

1 reference

12 December 2020

10.1007/S11046-009-9232-6

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1039911031

0 references

1 reference